<?xml version="1.0" encoding="UTF-8"?>
<p>There is a wide range of prevalence estimates among developing countries and generally less data available to validate assumptions about the burden of disease than in the developed world. This range in prevalence is reflected in reviewing the estimates from developing countries that are among the world’s most populous nations (Population Reference Bureau 
 <xref ref-type="bibr" rid="CR140">2004</xref>). China, whose citizens account for one-fifth of the world’s population, has a reported seroprevalence of 3.2 % (Xia et al. 
 <xref ref-type="bibr" rid="CR184">1996</xref>). In India, which holds an additional one-fifth of the world’s population, one community-based survey reported an overall rate of 0.9 % (Chowdhury et al. 
 <xref ref-type="bibr" rid="CR27">2003</xref>).
</p>
